Pacific Shuanglin Bio-pharmacy , Ltd. Current Assets

The latest current assets for 000403.SZ is $3.8B as of September 2026. That compares with $3.8B in the prior-year period — down 0.2% year over year. Investors often review this figure alongside Pacific Shuanglin Bio-pharmacy , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 000403.SZ's current assets moved from $3.8B to $3.8B — a 0.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Pacific Shuanglin Bio-pharmacy , Ltd.'s operating scale or balance-sheet position.

A current assets figure of $3.8B for 000403.SZ is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 000403.SZ's current assets ($3.8B), review year-over-year change from $3.8B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Pacific Shuanglin Bio-pharmacy , Ltd.'s current assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.